Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harris A Ahmad

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Advances in Therapy|January 26, 2018
Association of Low Bone Mineral Density with Anti-Citrullinated Protein Antibody Positivity and Disease Activity in Established Rheumatoid Arthritis: Findings from a US Observational CohortHarris A Ahmad, Evo Alemao, Zhenchao Guo, et al.
Journal of Crohn'S & Colitis|February 22, 2023
Artificial Intelligence in Inflammatory Bowel Disease Endoscopy: Implications for Clinical TrialsHarris A Ahmad, James E East, Remo Panaccione, et al.
Rheumatology (Oxford, England)|January 19, 2013
Rate of adjudication of radiological progression in rheumatoid arthritis randomized controlled trials depending on preset limits of agreement: a pooled analysis from 15 randomized trialsVictoria Navarro-Compán, Robert Landewé, Harris A Ahmad, et al.
Arthritis Care & Research|September 25, 2019
Baseline Objective Inflammation by Magnetic Resonance Imaging as a Predictor of Therapeutic Benefit in Early Rheumatoid Arthritis With Poor PrognosisHarris A Ahmad, Joshua F Baker, Mikkel Østergaard, et al.
Digestive Diseases (Basel, Switzerland)|September 27, 2023
Considerations for Colorectal Neoplasia Detection in Inflammatory Bowel Disease Clinical TrialsMira M Yang, Keith Usiskin, Harris A Ahmad, et al.
Rheumatology International|October 21, 2018
On-drug and drug-free remission by baseline symptom duration: abatacept with methotrexate in patients with early rheumatoid arthritisVivian P Bykerk, Gerd R Burmester, Bernard G Combe, et al.
RMD Open|June 28, 2019
Body mass index and treatment response to subcutaneous abatacept in patients with psoriatic arthritis: a <i>post hoc</i> analysis of a phase III trialIain B McInnes, Gianfranco Ferraccioli, Maria-Antonietta D'Agostino, et al.
Rheumatology International|February 6, 2019
Correction to: On-drug and drug-free remission by baseline symptom duration: abatacept with methotrexate in patients with early rheumatoid arthritisVivian P Bykerk, Gerd R Burmester, Bernard G Combe, et al.
Arthritis Research & Therapy|February 17, 2022
Prediction of flare following remission and treatment withdrawal in early rheumatoid arthritis: post hoc analysis of a phase IIIb trial with abataceptHarris A Ahmad, Joshua F Baker, Philip G Conaghan, et al.
Rheumatology (Oxford, England)|February 9, 2022
Implementation of the OMERACT Psoriatic Arthritis Magnetic Resonance Imaging Scoring System in a randomized phase IIb study of abatacept in psoriatic arthritisMikkel Østergaard, Paul Bird, Chahin Pachai, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Advances in Therapy|January 26, 2018
Association of Low Bone Mineral Density with Anti-Citrullinated Protein Antibody Positivity and Disease Activity in Established Rheumatoid Arthritis: Findings from a US Observational CohortHarris A Ahmad, Evo Alemao, Zhenchao Guo, et al.
Journal of Crohn'S & Colitis|February 22, 2023
Artificial Intelligence in Inflammatory Bowel Disease Endoscopy: Implications for Clinical TrialsHarris A Ahmad, James E East, Remo Panaccione, et al.
Rheumatology (Oxford, England)|January 19, 2013
Rate of adjudication of radiological progression in rheumatoid arthritis randomized controlled trials depending on preset limits of agreement: a pooled analysis from 15 randomized trialsVictoria Navarro-Compán, Robert Landewé, Harris A Ahmad, et al.
Arthritis Care & Research|September 25, 2019
Baseline Objective Inflammation by Magnetic Resonance Imaging as a Predictor of Therapeutic Benefit in Early Rheumatoid Arthritis With Poor PrognosisHarris A Ahmad, Joshua F Baker, Mikkel Østergaard, et al.
Digestive Diseases (Basel, Switzerland)|September 27, 2023
Considerations for Colorectal Neoplasia Detection in Inflammatory Bowel Disease Clinical TrialsMira M Yang, Keith Usiskin, Harris A Ahmad, et al.
Rheumatology International|October 21, 2018
On-drug and drug-free remission by baseline symptom duration: abatacept with methotrexate in patients with early rheumatoid arthritisVivian P Bykerk, Gerd R Burmester, Bernard G Combe, et al.
RMD Open|June 28, 2019
Body mass index and treatment response to subcutaneous abatacept in patients with psoriatic arthritis: a <i>post hoc</i> analysis of a phase III trialIain B McInnes, Gianfranco Ferraccioli, Maria-Antonietta D'Agostino, et al.
Rheumatology International|February 6, 2019
Correction to: On-drug and drug-free remission by baseline symptom duration: abatacept with methotrexate in patients with early rheumatoid arthritisVivian P Bykerk, Gerd R Burmester, Bernard G Combe, et al.
Arthritis Research & Therapy|February 17, 2022
Prediction of flare following remission and treatment withdrawal in early rheumatoid arthritis: post hoc analysis of a phase IIIb trial with abataceptHarris A Ahmad, Joshua F Baker, Philip G Conaghan, et al.
Rheumatology (Oxford, England)|February 9, 2022
Implementation of the OMERACT Psoriatic Arthritis Magnetic Resonance Imaging Scoring System in a randomized phase IIb study of abatacept in psoriatic arthritisMikkel Østergaard, Paul Bird, Chahin Pachai, et al.
Pageof 3